Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | RO7119929 |
Synonyms | |
Therapy Description |
RO7119929 is a TLR7 agonist, potentially resulting in antitumor immune activity (Cancer Res (2023) 83 (8_Supplement): CT096). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
RO7119929 | RO-7119929|RO 7119929 | TLR7 Agonist 12 | RO7119929 is a TLR7 agonist, potentially resulting in antitumor immune activity (Cancer Res (2023) 83 (8_Supplement): CT096). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|